Compare AMH & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMH | ARWR |
|---|---|---|
| Founded | 2012 | 2003 |
| Country | United States | United States |
| Employees | 1598 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.2B |
| IPO Year | N/A | 2009 |
| Metric | AMH | ARWR |
|---|---|---|
| Price | $33.23 | $73.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 19 | 10 |
| Target Price | $34.92 | ★ $83.40 |
| AVG Volume (30 Days) | ★ 3.1M | 1.5M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,142,321.00 |
| Revenue This Year | $2.69 | N/A |
| Revenue Next Year | $2.26 | N/A |
| P/E Ratio | $26.59 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.22 | $14.30 |
| 52 Week High | $37.10 | $82.26 |
| Indicator | AMH | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 69.12 | 46.21 |
| Support Level | $32.05 | $70.49 |
| Resistance Level | $33.49 | $77.39 |
| Average True Range (ATR) | 0.60 | 3.63 |
| MACD | 0.05 | -0.89 |
| Stochastic Oscillator | 95.53 | 26.81 |
American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.